FDA Public Health Advisory

Tegison (Etretinate) is a derivative of vitamin A and has been prescribed for the treatment of severe psoriasis. It was withdrawn from the market when it was found to increase the possibility of birth defects. Major fetal abnormalities related to Tegison, including neurologic and skeletal deformities, have been reported.

Blood Donor Refusal

Due to potential harm to blood recipients who are or may become pregnant, the FDA recommends that any donor who has taken or is taking Tegison should be permanently deferred.

Possible Tegison Birth Defects Lawsuit

If you or a family member have taken Tegison and have experienced birth defects, you may be entitled to compensation.

Register your Tegison Complaint with a Lawyer

If you feel you qualify for damages or remedies that might be awarded in a possible Tegison lawsuit or class action, please fill in our form on the right to submit your complaint.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help